Neptune Technologies & Bioressources Inc (NEPT.TO)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2017||Chairman of the Board|
|2015||President, Chief Executive Officer, Director|
|2015||Chief Financial Officer|
|2013||Senior Vice President of Sales - Global Sales|
|Chief Operating Officer of Acasti|
- BRIEF-Neptune Technologies & Bioressources Q3 Net Income $1.3 Mln Vs $9.4 Mln
- BRIEF-Neptune, Tetra Bio-Pharma Enter Co-Development Agreement For Purified Cannabinoid Oil-Based Products Targeting Pain, Inflammation
- BRIEF-Neptune And Tetra Bio-Pharma Sign Co-Development Agreement
- BRIEF-Neptune Technologies Announces Research Agreement Aimed At Medical Cannabinoid-Based Products
- BRIEF-Neptune Announces Research Agreement Aimed At New Medical And Wellness Cannabinoid-Based Products